Attached files
EXHIBIT 12.1
JAZZ PHARMACEUTICALS, INC.
RATIO OF EARNINGS TO FIXED CHARGES
| Year Ended December 31, | ||||||||||
| 2009 | 2008 | 2007 | 2006 | 2005 | ||||||
| Ratio of earnings to fixed charges (1) |
N/A | N/A | N/A | N/A | N/A | |||||
| (1) | Our earnings were insufficient to cover fixed charges by $6.8 million, $184.3 million, $138.8 million, $59.4 million and $85.2 million for the years ended December 31, 2009, 2008, 2007, 2006 and 2005, respectively. |
COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES
(In thousands)
| Year Ended December 31, | ||||||||||||||||||||
| 2009 | 2008 | 2007 | 2006 | 2005 | ||||||||||||||||
| EARNINGS: |
||||||||||||||||||||
| Loss before income taxes |
$ | (6,836 | ) | $ | (184,339 | ) | $ | (138,826 | ) | $ | (59,391 | ) | $ | (85,156 | ) | |||||
| Plus: fixed charges (see below) |
23,481 | 21,037 | 14,150 | 14,458 | 7,361 | |||||||||||||||
| Total income (loss) to cover fixed charges |
16,645 | (163,302 | ) | (124,676 | ) | (44,933 | ) | (77,795 | ) | |||||||||||
| FIXED CHARGES: |
||||||||||||||||||||
| Interest expense |
20,249 | 17,535 | 12,256 | 12,757 | 6,422 | |||||||||||||||
| Amortization of capitalized expenses and accretion of debt discount related to indebtedness |
2,547 | 2,207 | 1,391 | 1,372 | 707 | |||||||||||||||
| Estimated interest portion of rental expense |
685 | 1,295 | 503 | 329 | 232 | |||||||||||||||
| Total fixed charges(1) |
23,481 | 21,037 | 14,150 | 14,458 | 7,361 | |||||||||||||||
| DEFICIENCY OF EARNINGS TO COVER FIXED CHARGES |
$ | (6,836 | ) | $ | (184,339 | ) | $ | (138,826 | ) | $ | (59,391 | ) | $ | (85,156 | ) | |||||
| (1) | For purposes of computing the ratio of earnings to fixed charges, fixed charges consist of interest expense on long and short term debt, amortization of deferred financing costs, accretion of a debt discount, interest imputed related to a government settlement obligation, interest related to a development financing obligation and a portion of rental expense deemed to be representative of interest. |